Valuation: Stryker Corporation

Market Cap 129B 112B 104B 95.99B 181B 12,292B 183B 1,226B 481B 6,150B 486B 475B 20,370B P/E 2026 *
26.2x
P/E 2027 * 22.8x
Enterprise Value 138B 120B 112B 103B 194B 13,160B 196B 1,313B 515B 6,585B 520B 508B 21,808B EV / Sales 2026 *
5.07x
EV / Sales 2027 * 4.55x
Free-Float
94.9%
Yield 2026 *
1.07%
Yield 2027 * 1.14%
1 day+0.93%
1 week-2.21%
Current month+4.67%
1 month+4.33%
3 months+16.89%
6 months-4.18%
Current year-3.76%
1 week 317.32
Extreme 317.32
350
1 month 299.41
Extreme 299.4099
360
Current year 281.04
Extreme 281.04
389.55
1 year 281.04
Extreme 281.04
396.86
3 years 250.79
Extreme 250.79
406.7
5 years 191.18
Extreme 191.18
406.7
10 years 127.68
Extreme 127.6758
406.7
Manager TitleAgeSince
Chief Executive Officer 60 2012-09-30
Director of Finance/CFO 50 2025-03-31
President 49 2025-12-31
Director TitleAgeSince
Director/Board Member 82 1973-12-31
Director/Board Member 71 1983-12-31
Chairman 60 2014-07-21
Change 5-day change 1-year change 3-year change Capi.($)
+0.93%-2.21% - - 129B
-0.11%-3.22%-10.16%+17.67% 129B
-1.06%-7.74%-18.06%-2.19% 12.56B
-0.66%+0.90%+92.15%+126.16% 10.08B
+0.24%+0.80%-42.81%-68.91% 4.7B
+0.51%-2.30%-18.54%+36.89% 2.63B
-9.23%-6.14%+6.75%-53.41% 1.74B
+0.27%+20.35%-23.26%-77.33% 1.74B
-0.33%-0.71%-16.75%-18.39% 1.67B
Average -1.05%+0.77%-3.83%-4.94% 20.55B
Weighted average by Cap. +0.25%-3.62%-5.58%+18.52%

Financials

2026 *2027 *
Net sales 27.29B 23.64B 22.03B 20.27B 38.26B 2,595B 38.69B 259B 102B 1,298B 103B 100B 4,300B 29.68B 25.71B 23.96B 22.04B 41.61B 2,822B 42.07B 282B 111B 1,412B 111B 109B 4,677B
Net income 4.94B 4.28B 3.99B 3.67B 6.93B 470B 7B 46.88B 18.4B 235B 18.56B 18.15B 779B 5.75B 4.98B 4.64B 4.27B 8.06B 546B 8.15B 54.52B 21.4B 273B 21.58B 21.11B 905B
Net Debt 9.13B 7.9B 7.37B 6.78B 12.79B 868B 12.93B 86.57B 33.98B 434B 34.27B 33.52B 1,438B 5.89B 5.1B 4.75B 4.37B 8.25B 560B 8.35B 55.86B 21.93B 280B 22.11B 21.63B 928B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change Volume
26-08-06 US$340.45 +2.06% 17
26-08-05 US$334.71 -0.44% 254
26-08-04 US$336.19 -0.79% 2,912
26-08-03 US$338.85 +4.18% 2,937
26-07-31 US$325.27 -6.57% 2,317
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
337.03USD
Average target price
382.04USD
Spread / Average Target
+13.35%

Quarterly revenue - Rate of surprise